C9 and amyotrophic lateral sclerosis: The expanded C9-NRE DNA is structurally polymorphic and forms non-canonical structures including GQs7,27–30, but it is still unknown if these structures could be an effective upstream therapeutic target for preventing C9-NRE-linked ALS/FTD.